Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa later this month, ...

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new ...

Victoza (active ingredient liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist medication manufactured by Novo ...

The hidden cost GLP boom shows total payments rose sharply from 2017-2022 despite lower out-of-pocket costs, impacting insurers and Medicare programs.

Dallas expected to save $12 million on employee healthcare this year, but rising GLP-1 drug use and high-cost claims now have ...

Employers are bracing for what could be the highest rise in health insurance premiums in 16 years, driving up the cost of ...

If you’ve ever tried to lose weight, you know how much effort it takes—early mornings, tough workouts, and staying consistent ...

The measure to change the county’s employee medical plan starting in 2027 passed narrowly following considerable discussion ...

About a dozen states offer "medically tailored meals" to people with conditions such as diabetes and heart disease who get ...

If you have diabetes, your health care provider may recommend Trulicity or Mounjaro, two medications approved by the U.S.

Insulin is not optional for people with diabetes — it is a daily need. It is not a luxury or something they can delay and go ...

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...